In a retrospective cohort study, Tamás Kassai, MD, and colleagues analyzed data on 24 children (mean age of 12.3 years at the time of injury) who received biodegradable implants (ActivaPin, Bioretec) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback